A. Avihingsanon

发表

Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.

K. Ruxrungtham, G. Suwanpimolkul, K. Kawkitinarong, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Differences Between Men Who Have Sex with Men (MSM) with Low CD4 Cell Counts at Their First HIV Test and MSM with Higher CD4 Counts in Bangkok, Thailand

R. Stall, M. Friedman, J. Sophonphan, 2016, AIDS and Behavior.

Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional study

J. Montaner, E. Wood, T. Kerr, 2015, Substance Abuse Treatment, Prevention, and Policy.

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients.

K. Ruxrungtham, A. Avihingsanon, B. Punyawudho, 2017, International journal of antimicrobial agents.

A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients

P. Phanuphak, S. Kerr, A. Sohn, 2016, Journal of virus eradication.

Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV

M. Law, R. Chaiwarith, O. Ng, 2021, HIV medicine.

Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.

J. Ananworanich, D. Cooper, A. Kelleher, 2014, The Journal of infection.

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.

M. Hughes, R. Schooley, R. Gross, 2019, The lancet. HIV.

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients

K. Ruxrungtham, A. Birnbaum, T. Bunupuradah, 2021, Expert review of clinical pharmacology.

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.

K. Ruxrungtham, S. Emery, T. Bunupuradah, 2019, Pharmacogenomics.

Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection

N. Chuaypen, P. Tangkijvanich, A. Avihingsanon, 2020, PloS one.

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

G. Bloomfield, C. Fichtenbaum, K. Ruxrungtham, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand.

P. Phanuphak, N. Teeratakulpisarn, A. Avihingsanon, 2012, AIDS research and human retroviruses.

Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality

N. van Kinh, R. Chaiwarith, O. Ng, 2019, Journal of acquired immune deficiency syndromes.

The 16th Bangkok International Symposium on HIV Medicine

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2013 .

Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy.

K. Ruxrungtham, S. Kerr, Supalak Phonphithak, 2015, AIDS research and human retroviruses.

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment.

C. Fletcher, A. Avihingsanon, V. Klinbuayaem, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tenofovir alafenamide nephrotoxicity: a case report and literature review

Y. Avihingsanon, S. Gatechompol, A. Avihingsanon, 2021, AIDS Research and Therapy.

Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific

A. Sohn, R. Chaiwarith, O. Ng, 2016, PloS one.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

Higher proportion of abnormal nutritional status among well suppressed HIV-infected elderly Asians compared to HIV-negative individuals.

K. Ruxrungtham, S. Kerr, Lalita Wattanachanya, 2020, AIDS research and human retroviruses.

Validation of the D: A: D Chronic Kidney Disease Risk Score Model among people living with HIV in the Asia-Pacific.

R. Chaiwarith, O. Ng, Y. Chan, 2020, Journal of Acquired Immune Deficiency Syndromes.

Low CD4 cell counts Are Associated with Carotid Plaque and Intima-Medial Thickness in Virologically Suppressed HIV-infected Asians older than 50 years.

S. Kerr, A. Chutinet, S. Gatechompol, 2019, AIDS research and human retroviruses.

Antiretroviral therapy for HIV-associated tuberculosis

A. Avihingsanon, A. Hemachandra, Jasper van de Lugt, 2009 .

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial.

R. Davey, H. Lane, K. Ruxrungtham, 2019, Clinical Infectious Diseases.

Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression

S. Lewin, S. Locarnini, P. Desmond, 2011, AIDS.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2013, AIDS research and human retroviruses.

How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries

Y. Yazdanpanah, A. Mostafa, A. Fontanet, 2015, Hepatology.

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants

N. Chuaypen, P. Tangkijvanich, S. Siripongsakun, 2022, PloS one.

Public Health Interventions Research Group Publications, last ten years 2012

J. Kaldor, J. Ananworanich, K. Ruxrungtham, 2012 .

Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand

S. Vermund, J. Ananworanich, K. Ruxrungtham, 2009, Sexually Transmitted Infections.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries

M. Egger, M. Yotebieng, L. Diero, 2018, bioRxiv.

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV

R. Chaiwarith, O. Ng, T. Merati, 2019, Journal of the International AIDS Society.

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand

K. Ruxrungtham, S. Kerr, A. Chutinet, 2019, Journal of virus eradication.

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

K. Ensrud, J. Shepherd, A. Schwartz, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial.

Samit R. Joshi, G. McComsey, Samir K. Gupta, 2016, The lancet. HIV.

Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.

K. White, M. Johnson, K. Squires, 2016, The lancet. HIV.

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2016, The lancet. HIV.

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study

K. Ruxrungtham, S. Sirivichayakul, P. Ohata, 2016, PloS one.

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2008, Hepatology.

An Integrated Approach to HIV Disclosure for HIV-Affected Families in Thailand

J. Ananworanich, P. Phanuphak, A. Avihingsanon, 2019, Journal of the International Association of Providers of AIDS Care.

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.

S. Hammer, J. Ananworanich, S. Sirivichayakul, 2009, AIDS research and human retroviruses.

Performance of a simple flow cytometric assay in diagnosing active tuberculosis.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2020, Tuberculosis.

Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model

F. Cobelens, F. van Leth, S. Kerr, 2022, BMC Infectious Diseases.

Efficacy of tenofovir disoproxil fumarate/ emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV–HBV coinfection in Thailand

S. Lewin, K. Ruxrungtham, S. Kerr, 2010, Antiviral therapy.

A Phase 2b randomised, controlled, partially blinded trial of the HIV Nucleoside Reverse Transcriptase Inhibitor BMS-986001 (AI467003): Weeks 24 and 48 Efficacy, Safety, Bone and Metabolic Results

Samit R. Joshi, G. McComsey, Samir K. Gupta, 2016 .

HIV and Noncommunicable Diseases: The Asian Perspective

J. Ananworanich, A. Avihingsanon, 2014, Journal of acquired immune deficiency syndromes.

The Association of Gender, Age, Efavirenz Use, and Hypovitaminosis D Among HIV-Infected Adults Living in the Tropics.

K. Ruxrungtham, S. Kerr, Y. Avihingsanon, 2016, AIDS research and human retroviruses.

The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy

K. Ensrud, A. Schwartz, B. Grund, 2020, HIV medicine.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Cardiovascular disease‐related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD)

R. Chaiwarith, O. Ng, F. Zhang, 2019, HIV medicine.

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2012, AIDS Research and Therapy.

Human immunodeficiency virus and acquired immune deficiency syndrome in Asia: an update

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017 .

Chronic kidney disease incidence and survival of Thai HIV-infected patients

J. Ananworanich, K. Pongpirul, W. Pongpirul, 2017, AIDS.

Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings

P. Ohata, A. Avihingsanon, W. Maek-a-nantawat, 2012, AIDS research and treatment.

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.

S. Lewin, K. Ruxrungtham, G. Dore, 2014, The Journal of infectious diseases.

Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV-infected Thais

K. Ruxrungtham, P. Phanuphak, J. Ananworanich, 2010, Journal of the International AIDS Society.

Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature

R. Chaiteerakij, A. Avihingsanon, S. Treeprasertsuk, 2019, World journal of gastroenterology.

Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity

S. Lewin, F. Luciani, S. Bent, 2016, AIDS.

Elimination of hepatitis C among HIV-positive population in Asia: old and new challenges

P. Tangkijvanich, P. Ohata, A. Avihingsanon, 2021, Future Virology.

Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand*

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2017, AIDS care.

Diabetes mellitus burden among people living with HIV from the Asia‐Pacific region

R. Chaiwarith, O. Ng, S. Pujari, 2019, Journal of the International AIDS Society.

Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.

K. Ruxrungtham, A. Chutinet, J. Sophonphan, 2021, AIDS research and human retroviruses.

HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia‐Pacific region: a longitudinal cohort study

R. Chaiwarith, O. Ng, Y. Chan, 2021, Journal of the International AIDS Society.

Decades research and implementation science of HIV prevention, treatment and cure: highlights from Symposium 2017

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017 .

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

S. Lewin, P. Revill, J. Torresi, 2020, PLoS pathogens.

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

S. Lewin, K. Ruxrungtham, P. Price, 2009, The Journal of infectious diseases.

Large transmission cluster of acute hepatitis C identified among HIV‐positive men who have sex with men in Bangkok, Thailand

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Peg‐interferon and ribavirin treatment in HIV/HCV co‐infected patients in Thailand: efficacy, safety and pharmacokinetics

P. Tangkijvanich, A. Avihingsanon, D. Burger, 2018, Tropical medicine & international health : TM & IH.

Dyslipidemia in an Asian Population After Treatment for Two Years With Protease Inhibitor-Containing Regimens

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2007, Journal of the International Association of Physicians in AIDS Care.

A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays.

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2012, Tuberculosis.

Chronic hepatitis C infection and liver disease in HIV co-infected patients in Asia

K. Ruxrungtham, M. Law, A. Sohn, 2017 .

Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia

D. Nash, R. Chaiwarith, F. Zhang, 2020, Journal of virus eradication.

Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia‐Pacific

R. Chaiwarith, Y. Chan, S. Pujari, 2022, Journal of medical virology.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region

P. Gorbach, R. Chaiwarith, O. Ng, 2022, HIV medicine.

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV

K. Ruxrungtham, S. Kerr, S. Gatechompol, 2018, AIDS Research and Therapy.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

K. Lichtenstein, F. Post, Samir K. Gupta, 2016, Journal of acquired immune deficiency syndromes.

The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono-Infection and HCV/HIV Co-Infection

N. Chuaypen, P. Tangkijvanich, S. Payungporn, 2018, Asian Pacific journal of cancer prevention : APJCP.

Long‐term loss to follow‐up in the TREAT Asia HIV Observational Database (TAHOD)

M. Law, R. Chaiwarith, O. Ng, 2019, HIV Medicine.

Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV.

S. Kerr, A. Avihingsanon, W. M. Han, 2022, The Journal of antimicrobial chemotherapy.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.

S. Lewin, K. Ruxrungtham, C. Thio, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.

Y. Avihingsanon, A. Avihingsanon, W. Jiamjarasrangsi, 2008, Transplantation proceedings.

Life Expectancy after Initiation of Combination Antiretroviral Therapy in Thailand

K. Ruxrungtham, S. Kerr, M. Law, 2017, Antiviral therapy.

Higher prevalence of QTc interval prolongation among virologically suppressed older people with HIV

S. Kerr, P. Ohata, A. Avihingsanon, 2022, AIDS.

Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions.

R. Murphy, S. Gatechompol, A. Avihingsanon, 2020, The Journal of infectious diseases.

Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, PloS one.

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults.

K. Ruxrungtham, J. Sophonphan, S. Gatechompol, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm3 in Thailand☆

P. Hansasuta, J. Ananworanich, K. Ruxrungtham, 2020, Journal of virus eradication.

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial

G. Robbins, P. Tebas, B. Linas, 2022, The lancet. Gastroenterology & hepatology.

Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis

Sebastian M. Gygli, M. Egger, M. Yotebieng, 2018, Antimicrobial Agents and Chemotherapy.

Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia‐Pacific

M. Law, R. Chaiwarith, O. Ng, 2019, HIV medicine.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

H. Lane, D. Cooper, A. Phillips, 2015, The New England journal of medicine.

PREDICTION MODEL OF PRETREATMENT HIV RNA LEVELS IN NAÏVE HIV-INFECTED PATIENTS : APPLICATION FOR RESOURCE-LIMITED SETTING

R. Chaiwarith, A. Avihingsanon, P. Kantipong, 2019 .

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

K. Ruxrungtham, P. Phanuphak, M. Leechawengwongs, 2015, AIDS Research and Therapy.

Non AIDS complications and treatment optimizations for HIV-1 infected Thai adult patients with and without TB or hepatitis

S. Lewin, K. Ruxrungtham, D. Cooper, 2013 .

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

S. Lewin, K. Ruxrungtham, P. Angus, 2008, Hepatology.

Treatment of HIV infection with once-daily regimens

K. Ruxrungtham, A. Avihingsanon, N. Permpalung, 2012, Expert opinion on pharmacotherapy.

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.

S. Lewin, K. Ruxrungtham, C. Thio, 2010, Virology.

HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment

S. Lewin, J. Sasadeusz, A. Avihingsanon, 2017, AIDS.

Characterization of hepatitis B virus mutations in untreated patients co‐infected with HIV and HBV based on complete genome sequencing

K. Ruxrungtham, P. Tangkijvanich, Y. Poovorawan, 2013, Journal of medical virology.

No Increase in Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, S. Sirivichayakul, 2010, Journal of Virology.

Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection

S. Lewin, K. Ruxrungtham, D. Cooper, 2009, Journal of Virology.

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV

L. Mohapi, E. Were, A. Avihingsanon, 2019, Southern African journal of HIV medicine.

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.

J. Ananworanich, K. Ruxrungtham, L. Ferradini, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and 48-Week Efficacy of Nevirapine: 400 mg Versus 600 mg per day in HIV–Tuberculosis Coinfection Receiving Rifampicin

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2008, Antiviral therapy.

The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD)

M. Law, R. Chaiwarith, O. Ng, 2017, Journal of the International AIDS Society.

Viral hepatitis and the cascade of care among people living with HIV in the Asia‐Pacific

S. Pujari, T. Merati, N. Kumarasamy, 2022, HIV medicine.

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy

Wei Zhao, S. Lewin, P. Revill, 2022, EBioMedicine.

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

S. Lewin, K. Ruxrungtham, C. Thio, 2011, PloS one.

Influence of ABCC2 and ABCC4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2015, Antimicrobial Agents and Chemotherapy.

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

S. Lewin, J. Sasadeusz, S. Bowden, 2020, Journal of acquired immune deficiency syndromes.

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection

J. Ananworanich, P. Tangkijvanich, A. Avihingsanon, 2013, AIDS Research and Therapy.

Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practice

K. Ruxrungtham, S. Kerr, S. Gatechompol, 2019, AIDS Research and Therapy.

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

C. Katlama, P. Sax, Y. Yazdanpanah, 2017, The lancet. HIV.

Plasma Tenofovir Concentrations and Proximal Tubular Dysfunction in HIV-Infected Adults Receiving Tenofovir in Thailand

K. Ruxrungtham, Y. Avihingsanon, J. Sophonphan, 2015 .

Loss to follow-up and Associated Factors of Patients in the National AIDS Program in Thailand

K. Ruxrungtham, S. Kerr, M. Law, 2018, Antiviral therapy.

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2017, Journal of virus eradication.

Active Voluntary Counseling and Testing With Integrated CD4 Count Service Can Enhance Early HIV Testing and Early CD4 Count Measurement: Experiences From the Thai Red Cross Anonymous Clinic in Bangkok, Thailand

P. Phanuphak, N. Teeratakulpisarn, A. Avihingsanon, 2011, Journal of acquired immune deficiency syndromes.

Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus‐1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy

A. Perelson, S. Lewin, K. Ruxrungtham, 2009, Hepatology.

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

S. Lewin, K. Ruxrungtham, G. Dore, 2013, PloS one.

Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals

S. Lewin, T. Schlub, Wei Zhao, 2022, Journal of virology.

Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand

P. Phanuphak, A. Avihingsanon, N. Phanuphak, 2022, BMC Public Health.

Prevalence of Hepatitis B and Hepatitis C Infection and Their Associated Factors Among HIV-Infected Individuals in Same-Day Antiretroviral Therapy Initiation Program in Bangkok, Thailand

P. Phanuphak, A. Avihingsanon, N. Phanuphak, 2021 .

Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.

H. Jessen, A. Winston, D. Cooper, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.

K. Ruxrungtham, D. Cooper, R. Autar, 2008, The Journal of antimicrobial chemotherapy.

A Low Dose of Ritonavir‐Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV‐1‐Infected Thai Adults

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2009, Clinical pharmacology and therapeutics.

Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis.

S. Gatechompol, S. Ubolyam, A. Avihingsanon, 2022, Drug metabolism and pharmacokinetics.

Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2012, AIDS research and human retroviruses.

High proportion of blood-borne and sexually transmitted infections among people deprived of liberty in a central male prison in Thailand: a cross-sectional study 2018-2019.

K. Ruxrungtham, P. Phanuphak, P. Tangkijvanich, 2022, AIDS research and human retroviruses.

Chronic hepatitis C infection and liver disease in HIV‐coinfected patients in Asia

K. Ruxrungtham, A. Sohn, M. Law, 2017, Journal of viral hepatitis.

P029: Safety of tenofovir alafenamide in renal impairment

K. Lichtenstein, F. Post, Samir K. Gupta, 2015 .

Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency

J. Ananworanich, D. Cooper, A. Kelleher, 2013, PloS one.

Where latest advances in HIV are shared: 21st Bangkok International Symposium on HIV Medicine

P. Phanuphak, S. Kerr, T. Puthanakit, 2019, Future Virology.

Population Pharmacokinetics of Nevirapine in Thai HIV-Infected Patients

W. Manosuthi, A. Avihingsanon, Thanaporn Wattanakul, 2014, Antiviral therapy.

Clinical pharmacology and pharmacokinetics of antiretrovirals in Asia

A. Avihingsanon, J. Lugt, 2010 .

Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia.

K. Ruxrungtham, S. Kerr, K. Suphapeetiporn, 2015, Journal of acquired immune deficiency syndromes.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

B. Autran, J. Ananworanich, K. Ruxrungtham, 2009, AIDS.

Impact of Baseline Virologic, Immunologic, and Demographic Characteristics on Virologic Responses in the Gemini Study

K. Ruxrungtham, S. Walmsley, A. Avihingsanon, 2012, HIV clinical trials.

Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand.

V. Shotelersuk, W. Manosuthi, S. Ubolyam, 2020, Clinical therapeutics.

Low-Dose Ritonavir-Boosted Atazanavir (200/100 mg) Maintained a High Virological Efficacy Up To 4 Years in Treatment-Experienced HIV-1 Infected Adults: A Prospective Cohort Study from Asia

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2015 .

Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, Antimicrobial Agents and Chemotherapy.

Neither Branded Nor Generic Lopinavir/Ritonavir Produces Adequate Lopinavir Concentrations at a Reduced Dose of 200/50 mg Twice Daily

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2012, Journal of acquired immune deficiency syndromes.

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2009, Antiviral therapy.

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV–hepatitis B virus coinfection

S. Lewin, M. Pinzani, M. Maini, 2022 .

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study

J. Ananworanich, S. Ubolyam, A. Avihingsanon, 2017, Journal of virus eradication.

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia

N. Chuaypen, P. Tangkijvanich, W. Prasithsirikul, 2022, BMC Infectious Diseases.

Efficacy of Elbasvir/Grazoprevir Therapy in HCV Genotype-1 with or without HIV Infection: Role of HCV Core Antigen Monitoring and Improvement of Liver Stiffness and Steatosis

N. Chuaypen, P. Tangkijvanich, A. Avihingsanon, 2020, Antiviral therapy.

Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.

J. Ananworanich, K. Ikuta, K. Ono, 2013, The Southeast Asian journal of tropical medicine and public health.

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features

D. Lauffenburger, B. Hirschel, J. Ananworanich, 2021, mBio.

Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults

D. Ward, K. Ruxrungtham, S. Walmsley, 2009, Journal of acquired immune deficiency syndromes.

Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and Failure

N. Kumarasamy, A. Avihingsanon, A. Kariminia, 2022, Journal of acquired immune deficiency syndromes.

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand

K. Ruxrungtham, S. Kerr, G. Suwanpimolkul, 2019, Journal of virus eradication.

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.

B. Gazzard, D. Cooper, C. Duncombe, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The influence of age‐associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV

R. Chaiwarith, O. Ng, S. Pujari, 2019, Journal of the International AIDS Society.

Application of Geriatric Principles and Care Models in HIV and Aging.

A. Avihingsanon, A. Sangarlangkarn, J. Appelbaum, 2017, Interdisciplinary topics in gerontology and geriatrics.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Patterns and prognosis of holding regimens for people living with HIV in Asian countries

R. Chaiwarith, O. Ng, Y. Chan, 2022, PloS one.

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

R. Schooley, R. Gross, J. Mellors, 2022, Journal of the International AIDS Society.

Treatment Modification after Second-Line Failure among People Living with HIV in Asia-Pacific

M. Law, R. Chaiwarith, O. Ng, 2020, Antiviral therapy.

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2011, AIDS.

Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

J. Ananworanich, U. Siangphoe, W. Manosuthi, 2009, AIDS.

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS

K. Ruxrungtham, A. Avihingsanon, O. Putcharoen, 2015, Drug design, development and therapy.

Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women

K. Squires, C. Kityo, A. Cheng, 2018, Journal of acquired immune deficiency syndromes.

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV

S. Kerr, Lalita Wattanachanya, S. Gatechompol, 2022, BMC Geriatrics.

Screening tools for targeted comprehensive geriatric assessment in HIV-infected patients 50 years and older

A. Justice, A. Avihingsanon, T. Apornpong, 2019, International journal of STD & AIDS.

Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study

S. Kerr, G. Suwanpimolkul, K. Kawkitinarong, 2021, BMC Public Health.

Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin.

C. Mantzoros, S. Tsiodras, A. Avihingsanon, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults

P. Phanuphak, S. Kerr, Lalita Wattanachanya, 2020, AIDS care.

Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV.

F. van Leth, S. Kerr, J. Sophonphan, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients

K. Ruxrungtham, P. Phanuphak, S. Eiam‐Ong, 2012, AIDS.

COVID-19 and HIV infection co-pandemics and their impact: a review of the literature

D. Kuritzkes, K. Ruxrungtham, S. Gatechompol, 2021, AIDS Research and Therapy.

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2016, PloS one.

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

K. Ruxrungtham, A. Kelleher, M. Karyana, 2022, HIV research & clinical practice.

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

S. Yerly, S. Tan, S. Murad, 2021, The lancet. Gastroenterology & hepatology.

Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial

S. Yerly, S. Tan, S. Murad, 2020, SSRN Electronic Journal.

No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

A. Winston, J. Lundgren, R. Price, 2018, AIDS.

Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy

A. Melzer, K. Crothers, M. Ristola, 2018, Journal of acquired immune deficiency syndromes.

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis

E. Bendavid, M. Law, S. Bautista-Arredondo, 2020, Journal of the International AIDS Society.

Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B.

S. Lewin, N. Chuaypen, P. Tangkijvanich, 2019, Asian Pacific journal of allergy and immunology.

CXCL-10, Interleukin-12 and Interleukin-21 are not Immunological Predictors of Hbeag Seroconversion in HIV-1–HBV Coinfection following HBV-Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, J. Sasadeusz, 2014, Antiviral therapy.

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis

M. Law, R. Chaiwarith, A. Avihingsanon, 2021, PloS one.

The Correlation between Hepatitis C Core Antigen and Hepatitis C Virus RNA Levels with Respect to Human Immunodeficiency Virus Status, Hepatitis C Virus Genotype and Interferon-Lambda-4 Polymorphism

P. Tangkijvanich, A. Theamboonlers, Y. Poovorawan, 2015, Intervirology.

New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes

K. Ruxrungtham, S. Kerr, Supalak Phonphithak, 2017, AIDS.

Cardiovascular Disease Incidence Projections in the TREAT Asia HIV Observational Database (TAHOD)

M. Law, R. Chaiwarith, O. Ng, 2019, Antiviral therapy.

CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis

R. Rajasuriar, R. Chaiwarith, Y. Chan, 2023, Journal of acquired immune deficiency syndromes.

Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial

S. Murad, K. Goh, A. Kamarulzaman, 2018 .

Mortality after loss to follow-up - a linkage study of people living with HIV in Thailand and Malaysia.

R. Chaiwarith, A. Avihingsanon, S. Kiertiburanakul, 2022, Journal of acquired immune deficiency syndromes.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

An alternative label-free DNA sensor based on the alternating-current electroluminescent device for simultaneous detection of human immunodeficiency virus and hepatitis C co-infection.

O. Chailapakul, N. Chuaypen, P. Tangkijvanich, 2021, Biosensors & bioelectronics.

Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study

M. Egger, M. Yotebieng, E. Carter, 2021, The Lancet. Microbe.

Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients

M. Egger, M. Yotebieng, R. Wilkinson, 2020, Antimicrobial Agents and Chemotherapy.

HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis

Liliana K. Rutaihwa, M. Egger, M. Yotebieng, 2020, Antimicrobial Agents and Chemotherapy.

Correlation Between Polypharmacy and Frailty Among Thai Older Persons Living with HIV.

J. Woodard, A. Avihingsanon, T. Apornpong, 2022, AIDS research and human retroviruses.

Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults

K. Ruxrungtham, J. Sophonphan, S. Gatechompol, 2018, Antiviral therapy.

Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV‐infected Thais

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2011, HIV medicine.

Multicentre accuracy trial of FUJIFILM SILVAMP TB LAM test in people with HIV reveals lot variability

K. Reither, M. Muyoyeta, C. Denkinger, 2022, medRxiv.

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

K. Ensrud, A. Schwartz, B. Grund, 2015, HIV medicine.

Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.

A. Mocroft, H. Furrer, A. Clarke, 2017, International journal of antimicrobial agents.

Decline in Serum 25 Hydroxyvitamin D Levels in HIV–Hbv-Coinfected Patients after Long-Term Antiretroviral Therapy

S. Lewin, J. Ananworanich, K. Ruxrungtham, 2014, Antiviral therapy.

Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania

Liliana K. Rutaihwa, J. Fellay, M. Yotebieng, 2022, medRxiv.

Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.

K. Ruxrungtham, P. Phanuphak, C. Duncombe, 2010, Journal of acquired immune deficiency syndromes.

Deterioration of nutritional status and its negative association with depression among older HIV-infected Asian population: a four-year longitudinal study.

Supalak Phonphithak, A. Avihingsanon, T. Siritientong, 2021, AIDS Research and Human Retroviruses.

Carotid intima-media thickness is not associated with neurocognitive impairment among people older than 50 years with and without HIV infection from Thailand.

S. Kerr, Naruchorn Kijpaisalratana, A. Chutinet, 2019, AIDS research and human retroviruses.

Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study

S. Kerr, S. Gatechompol, A. Avihingsanon, 2022, PloS one.

HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART

J. Ananworanich, P. Reiss, S. Kerr, 2018, Journal of virus eradication.

Prevalence and risk of residual viremia after ART in low- and middle-income countries

J. Lifson, K. Ruxrungtham, S. Kerr, 2021, Medicine.

Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.

K. Ruxrungtham, G. Suwanpimolkul, K. Kawkitinarong, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Maintenance of statin therapy among people living with HIV.

S. Kerr, A. Avihingsanon, P. Chattranukulchai, 2020, AIDS.

Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection.

I. Nookaew, S. Cheevadhanarak, N. Chuaypen, 2021, The Journal of infectious diseases.

Liver fibrosis improvement assessed by magnetic resonance elastography and Mac‐2‐binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct‐acting antivirals

N. Chuaypen, P. Tangkijvanich, Yasuhito Tanaka, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

The 15th Bangkok international symposium on HIV medicine.

J. Ananworanich, K. Ruxrungtham, P. Phanuphak, 2009 .

Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination

A. Rancourt, C. Fichtenbaum, P. Douglas, 2020, HIV research & clinical practice.

Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais

J. Ananworanich, P. Phanuphak, S. Kerr, 2015, AIDS care.

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok

J. Kaldor, J. Ananworanich, K. Ruxrungtham, 2012, The open virology journal.

LPS , immune activation and liver abnormalities in HIV-HBV co-infected individuals on HBV-active combination antiretroviral therapy

Doré, Pushparaj, S. Lewin, 2014 .

Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

K. Ruxrungtham, P. Tangkijvanich, Y. Poovorawan, 2014, Journal of gastroenterology and hepatology.

Genotype and allele frequencies of ABCB 1 and SLCO 1 B 1 polymorphisms in THAI HIV-infected patients

T. Bunupuradah, N. Singkham, A. Avihingsanon, 2018 .

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

K. Ruxrungtham, C. Sukasem, A. Avihingsanon, 2017, Pharmacogenomics.

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials

Tak-Lam Wong, A. Avihingsanon, P. Chetchotisakd, 2022, HIV medicine.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-Sensitivity Troponins and Subclinical Coronary Atherosclerosis Evaluated by Coronary Calcium Score Among Older Asians Living With Well-Controlled Human Immunodeficiency Virus

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Open forum infectious diseases.

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

R. Paredes, H. Furrer, A. Phillips, 2023, NEJM evidence.

Influence of ABCC 2 and ABCC 4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2017 .

Inﬂuence of ABCC2 and ABCC4 Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients

K. Ruxrungtham, A. Avihingsanon, D. Burger, 2015 .

Ending AIDS and challenges for Asia

K. Ruxrungtham, P. Phanuphak, W. Prasitsuebsai, 2015 .

Treatment Strategy for Rifampin-Susceptible Tuberculosis.

A. Crook, A. Nunn, N. Paton, 2023, The New England journal of medicine.

Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020

A. Sohn, S. Pujari, N. Kumarasamy, 2023, PloS one.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Comparison of Routine Drug Susceptibility Testing with Whole-genome

M. Yotebieng, E. Carter, R. Wilkinson, 2020 .

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2020, Journal of the Pediatric Infectious Diseases Society.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy

K. Ruxrungtham, S. Kerr, G. Suwanpimolkul, 2022, Journal of the International AIDS Society.

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial.

J. Baeten, C. Hung, Taisheng Li, 2023, The lancet. HIV.

HIV medicine as double-sided sword: care and prevention

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2018 .

Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection.

I. Nookaew, N. Chuaypen, P. Tangkijvanich, 2023, Scientific reports.

Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.

S. Lewin, K. Ruxrungtham, A. Avihingsanon, 2015, International journal of clinical pharmacology and therapeutics.

Conference proceedings from hybrid 25th Bangkok International Symposium on HIV Medicine

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Future Virology.

Pharmacokinetics and 48-Week Safety and Efficacy of Generic Lopinavir/Ritonavir in Thai HIV-Infected Patients

J. Ananworanich, P. Phanuphak, J. Sophonphan, 2013, Antiviral therapy.

Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.

K. Ruxrungtham, S. Kerr, P. Tangkijvanich, 2020, Journal of acquired immune deficiency syndromes.

Assessing adherence in Thai patients taking combination antiretroviral therapy

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2012, International journal of STD & AIDS.

Factors associated with reduced function and quality of life among adult people with HIV with depression and substance use in the Asia-Pacific region

M. Law, A. Sohn, R. Rajasuriar, 2022, AIDS.

Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.

C. Kityo, V. Pokrovsky, A. Avihingsanon, 2019, Journal of acquired immune deficiency syndromes.

High-Sensitivity Troponins and Subclinical Coronary Atherosclerosis Evaluated by Coronary Calcium Score Among Older Asians Living With Well-Controlled Human Immunodeficiency Virus

K. Ruxrungtham, P. Phanuphak, S. Kerr, 2023, Open forum infectious diseases.

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV–hepatitis B virus coinfection

S. Lewin, M. Pinzani, M. Maini, 2022, AIDS.

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

S. Lewin, K. Ruxrungtham, D. Cooper, 2008, Hepatology.

Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers–Led Model for HCV Microelimination in Thailand

P. Tangkijvanich, J. Sophonphan, S. Ubolyam, 2021, Journal of acquired immune deficiency syndromes.

Impact of steatotic liver disease and non‐alcoholic steatohepatitis on cognitive impairment in people living with HIV: A cross‐sectional study

S. Gatechompol, S. Ubolyam, A. Avihingsanon, 2023, HIV medicine.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.

A Randomized Double-Blind Phase 2 Study of Combination Antivirals for the Treatment of Influenza

M. Hughes, R. Schooley, R. Davey, 2017, The Lancet. Infectious diseases.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

M. Egger, M. Yotebieng, L. Diero, 2019, The Lancet. Infectious diseases.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries

M. Yotebieng, L. Diero, A. Abimiku, 2018, bioRxiv.

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.

S. Hammer, J. Ananworanich, S. Sirivichayakul, 2009, AIDS research and human retroviruses.

The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case–control study

S. Gatechompol, S. Ubolyam, A. Avihingsanon, 2024, BMC infectious diseases.

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection

P. Tangkijvanich, W. Prasithsirikul, A. Avihingsanon, 2024, Clinical and translational science.

Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation

F. van Leth, F. Cobelens, M. Nyirenda, 2023, AIDS.

Electrochemical capillary-driven microfluidic DNA sensor for HIV-1 and HCV coinfection analysis.

O. Chailapakul, N. Chuaypen, P. Tangkijvanich, 2023, Analytica chimica acta.

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.

J. Ananworanich, K. Ruxrungtham, L. Ferradini, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

A. Avihingsanon, M. Crane, J. Audsley, 2024, EBioMedicine.

Conference proceedings from the 22nd Bangkok International Symposium on HIV Medicine

P. Phanuphak, S. Kerr, S. Gatechompol, 2020 .

Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy

J. Ananworanich, K. Ruxrungtham, S. Kerr, 2012, Antimicrobial Agents and Chemotherapy.